Brain47Brain47Join Brain47
29C1

CareRx Corporation

Healthcare · EUR · F

29C1

Price

€2.173

-1.67%

Cap

€234.22M

Earnings

—

30d Trend

-4.6%

29C1
Loading chart data...
0 days · % change from startPowered by Brain47
VolatilityModerate

22% annualised over 90 days

BRAIN47 SIGNAL

0
STRONG
Risk Level35
Quality64
Momentum70
Technical38
Fundamentals59

Raw weighted: 60×Macro 0.99 (−1%)=59

RISK

35/100
90d Volatility
21.7%Moderate
ATR %
2.9%Normal
Max Drawdown (1Y)
-12.7%Resilient

QUALITY

64/100
ROE (avg)
23.9%Excellent
Piotroski F-Score
8/9Strong
Debt/Equity
0.71Moderate
Margin Stability
CV 93.4%Volatile
Accruals
-0.0%Cash earnings

MOMENTUM

70/100
12-1M Momentum
+27.2%Strong uptrend
6-1M Momentum
+5.0%Flat
1M Return
-7.0%Recent pullback
Relative Strength
+1.2% vs sectorIn-line

TECHNICAL

38/100
RSI (14)
37.3Neutral
Price vs SMA200
-3.4%Bearish trend
MACD
0.00Bearish momentum
Bollinger Band
18%Near lower band
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.333Mixed

FUNDAMENTALS

59/100
EV/EBIT
29.2Expensive
P/FCF
10.4Cheap
P/S
0.6Cheap
Shareholder Yield
1.5%Low

Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months43
3-12 months40
1-5+ years ★62

Long-term compounder — quality business with growth runway

BRAIN47'S ASSESSMENT

I rate CareRx Corporation at 59/100 — a STRONG reading on the Brain47 Signal. The strongest factor is momentum at 70/100. I classify this as a growth position with the strongest thesis on a long-term horizon.

PAST PERFORMANCE

1 MONTH

-7.0%

3 MONTHS

-9.2%

12 MONTHS

+20.1%

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Long-term compounder — quality business with growth runway. Momentum (70) and low-risk profile are the primary strengths. I note that technical is the weakest area at 38/100 — this warrants monitoring. Historical volatility is normal at 22%. I classify this as a growth position — strong momentum combined with solid fundamentals points to capital appreciation.

growthScore: 59/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.